November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Statement at Finance Hearing on the Inflation Reduction Act and Lower Health Care Costs
- Wyden Statement on Trump’s Latest Campaign Proposal on Taxes
- Wyden Praises Biden-Harris Effort to Stem the Flow of Fentanyl From Overseas
- Wyden Hearing Statement on Ultra-Wealthy Tax Dodging and the 2025 Tax Debate
- Wyden Introduce Bipartisan Legislation to Improve Short Line and Regional Railroad Tax Credit